Moreover, CRELD1 acts as an upstream modulator of Wnt signaling, and its upregulation can restore blood–brain barrier dysfunctions due to the disruption of brain endothelial cells that is characteristic of AD [64]. Here, CRELD1 is linked to Alzheimer disease.